Patients that receive heart transplants with DCD hearts have comparable early renal outcomes to patients that receive hearts donated after brain death.
In a population of cisgender men, transgender women, transgender men, and gender-nonbinary persons, the incidence of HIV is lower with receipt of twice-yearly subcutaneous lenacapavir.